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Abstract
The current study has investigated the use of decellularised, demineralised bone extracellu-
lar matrix (ECM) hydrogel constructs for in vivo tissue mineralisation and bone formation.
Stro-1-enriched human bone marrow stromal cells were incorporated together with select
growth factors including VEGF, TGF-β3, BMP-2, PTHrP and VitD3, to augment bone forma-
tion, and mixed with alginate for structural support. Growth factors were delivered through
fast (non-osteogenic factors) and slow (osteogenic factors) release PLGAmicroparticles.
Constructs of 5 mm length were implanted in vivo for 28 days within mice. Dense tissue
assessed by micro-CT correlated with histologically assessed mineralised bone formation
in all constructs. Exogenous growth factor addition did not enhance bone formation further
compared to alginate/bone ECM (ALG/ECM) hydrogels alone. UV irradiation reduced bone
formation through degradation of intrinsic growth factors within the bone ECM component
and possibly also ECM cross-linking. BMP-2 and VitD3 rescued osteogenic induction. ALG/
ECM hydrogels appeared highly osteoinductive and delivery of angiogenic or chondrogenic
growth factors led to altered bone formation. All constructs demonstrated extensive host tis-
sue invasion and vascularisation aiding integration and implant longevity. The proposed
hydrogel system functioned without the need for growth factor incorporation or an exoge-
nous inducible cell source. Optimal growth factor concentrations and spatiotemporal
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release profiles require further assessment, as the bone ECM component may suffer batch
variability between donor materials. In summary, ALG/ECM hydrogels provide a versatile
biomaterial scaffold for utilisation within regenerative medicine which may be tailored, ulti-
mately, to form the tissue of choice through incorporation of select growth factors.
Introduction
There is a growing socio-economic need for new efficacious methods to repair bone damage in
vivo. In an increasingly aged population, bone defects resulting from trauma [1, 2], disease
(osteonecrosis [3], osteoporosis [4, 5], and Paget’s disease [6]), and/or surgical intervention
(bone excision [7]), pose a significant challenge and accentuate the need for bone tissue engi-
neering strategies [8]. Current clinical reparative practice involves the utilisation of autogenic
and allogenic bone grafts for replacement, repair, and regeneration [9, 10]. However, limita-
tions include availability, complex decellularisation and sterilisation procedures, disease trans-
mission, donor site morbidity, bone union efficacy, immunogenic/inflammatory responses as
well as significant variability in osteoconductivity, osteoinductivity, and vascularisation capac-
ity. To address some of these issues, osteogenic growth factors such as bone morphogenetic
protein 2 (BMP-2) can be combined with autografts and allografts to improve clinical outcome
[11, 12]. Furthermore, rapid clearance, a need for localised concentration, and a short half-life
in vivo, have all contributed to the requirement of supraphysiological (milligram) doses of
BMPs to elicit a sufficient bone healing response. Consequently, a platform shift towards tis-
sue-engineered constructs is a current research focus [13–15].
Bone tissue engineering has centred on a number of fundamental cornerstones; i) an induc-
ible cell source, ii) inductive signalling, and iii) an appropriate, potentially bioactive scaffold.
For bone bioengineering, skeletal stem cells (SSCs) provide an ideal cell source due to their
self-renewal and osteochondral differentiation potential. Select growth factors can provide
inductive signals for angio-, chondro-, and osteo-genesis whilst delivery vehicles can be utilised
to encapsulate these growth factors and provide spatiotemporal release in vivo, recreating
microenvironmental and developmental cues [16, 17]. Encapsulation can be achieved within
the scaffold material or within microparticles added to the scaffold [18–21]. Finally, the scaf-
fold component typically offers structural integrity and support during cellular colonisation
and eventual tissue regeneration. Suitable scaffolds should support and direct cell growth and
tissue formation, replicate native 3D architecture, withstand mechanical and physiological
loading and stresses, and exhibit function-dependent biodegradation without production of
toxic by-products [22–25].
Hydrogels have long been used for tissue regeneration due to their capacity to replicate
characteristics inherent to extracellular matrix (ECM) [26–28]. Hydrogels can in part, mimic
in vivo environments replicating cell-matrix, and enabling homo/hetero-geneous cell-cell inter-
actions [29]. Furthermore, hydrogels can aid nutrient and gaseous transfer, removal of meta-
bolic waste products and signal transduction, fulfilling their clinical application as a minimally
invasive injectable (due to their liquid/gel structure) void filler for in vivo tissue regeneration
[30]. However, there remains debate over the structure and composition of hydrogels and how
these features affect clinical efficacy [31]. Hydrogels typically no longer resemble the intrinsic
3D architecture of native tissues, and it is unclear whether essential microenvironmental cues
including cytokines, growth factors, and hormones are retained [29]. To address these con-
cerns, hydrogels can be tailored to exhibit desired material properties [32] including i) charge
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and porosity [33–35], ii) structure and scaffold mechanics [36, 37] and iii) the addition of
growth factors (i.e. BMP-2 for bone) to reconstitute in part, microenvironmental cues [38] to
aid tissue regeneration [39–42].
The current study has examined a bone ECM-derived hydrogel [43–45] based on previous
work using demineralised bone matrix (DBM), including application in an ex vivo organotypic
model [46–49]. In vivo studies utilising DBM have long demonstrated capacity for bone regen-
eration [43–45]. However, use of DBM has resulted in variable clinical success due to study
dependent differences in processing and preparation, donor variability, and inflammatory
response [50, 51]. Derivation of purified bone ECM through removal of cell debris and lipids,
previously described by Sawkins M. J. et al [52], has produced a hydrogel matrix composed pri-
marily of macromolecules, highly conserved across animal species which reduces potential
immunogenic and inflammatory response [53, 54]. This bone ECM component has been com-
bined with alginate to improve structural stability through ionic cross-linking. The new algi-
nate/bone ECM (ALG/ECM) hydrogels were seeded with SSCs (Stro-1-enriched human bone
marrow stromal cells (HBMSCs)) and growth factor loaded microparticles to examine bone
formation capacity. Microparticles were fabricated from a widely used biodegradable hydro-
philic polymer, poly(D,L-lactic-co-glycolic acid) (PDLLGA) [55–58], combined with an ‘in-
house’ Triblock polymer (PDLLGA-PEG-PDLLGA) [59, 60]. Microparticles were fabricated in
two sizes with different volumes of Triblock, providing two distinct release profiles. Large (50–
100μm) microparticles with 30% Triblock provided a fast release profile, whilst small (20–
30μm) microparticles with 10% Triblock provided a slow release profile [60]. Microparticles
were loaded with individual angiogenic (VEGF–fast release), chondrogenic (TGF-β3 –fast
release), and osteogenic (BMP-2, PTHrP, or VitD3 –slow release) growth factors, and human
serum albumin (HSA) as a carrier protein. Hydrogel constructs were implanted subcutane-
ously within immuno-deficient mice for 28 days to assess bone formation.
The current study has employed a multifactorial approach to bone tissue engineering; thus
osteoinductive ECM hydrogels, stabilised with alginate, were loaded with SSCs and microparti-
cle-encapsulated growth factors to investigate bone development and tissue formation in vivo.
The long-term goal was to assess whether a multifaceted approach could improve on current
bone regeneration strategies. Based on current knowledge in the bone bioengineering field, the
authors hypothesise the proposed system combines elements from several tissue engineering
approaches to enhance bone formation in vivo, comparable to that required in a clinical setting.
Specifically, we hypothesise, ECM hydrogels containing growth factor loaded microparticles
can induce bone formation.
Materials and Methods
All materials were purchased from Sigma Aldrich unless otherwise stated.
Ethics statement
The use of human material in this study was approved by the NHS/University of Southampton
local research governing office (ref no: 6418) and by the Southampton NHS research and
development committee (ref no: T&O/079) as well as the Southampton and South West
Hampshire Local Research Ethics Committee (LREC: 194/99/1). Human bone marrow was
collected following informed consent (approval from the LREC) from patients undergoing
total hip-replacement surgery. Written consent was obtained from each informed patient prior
to surgery. Information was recorded and logged on a central database. The consent form was
maintained with patients’medical-records files. According to the terms of the ethical approval,
the patient samples were anonymised/unlinked. We received only basic information including
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the age and gender of each patient sample. Collection of samples was recorded and reported
annually to the ethical research governing body and the Human Tissue Authority as approved
by the Southampton and South West Hampshire LREC. All animal procedures were carried
out in accordance with the guidelines and regulations laid down in the Animals (Scientific Pro-
cedures) Act 1986. MF1 nu/nu mice were sacrificed after 28 days by schedule 1 CO2 inhalation
and cervical dislocation according to Home Office Approval UK (Project license–PPL 30/
2762). All surgery was performed under anaesthesia/analgesia, and all efforts were made to
minimise suffering.
Marrow preparation and cell isolation
Human bone marrow was collected from haematologically normal osteoarthritic patients
(4 patients, mean age 63) undergoing total hip-replacement surgery at the Southampton Gen-
eral Hospital. Cells were isolated and enriched as described by Gothard D. et al. [61] In brief,
marrow was suspended in modified eagle’s medium—alpha (α-MEM) and centrifuged at 1000
rpm for 4 min to remove fat. Marrow was then passed through a 40 μm sieve to remove blood
clots and bone fragments. Red blood cells were also removed via centrifugation at 2200 rpm
and 18°C for 40 min using LymphoPrep™ (Lonza). Isolated cells were washed with phosphate
buffered saline (PBS, Lonza) and suspended in blocking buffer (α-MEM, 10% human serum,
5% foetal calf serum (FCS) and 10 mg/mL bovine serum albumin (BSA)) for 15 min at 4°C.
Cells were then incubated with neat primary antibody (anti-human Stro-1+, Hybridoma) for
30 min at 4°C before washing with isolation buffer (0.5% BSA and 2 mM ethylenediaminetetra-
acetic acid (EDTA) in dH2O) as previously detailed [62]. Labelled cells were then incubated
with magnetic bead conjugated secondary antibody (200 μL in 800 μL isolation buffer, Miltenyi
Biotec) for 15 min at 4°C before further washes. Stro-1+ cells were then separated by MACS
before in vitro culture expansion in basal media (α-MEM, 10% FCS, penicillin (100 U/mL) and
streptomycin (0.1 mg/mL)) to 80% confluency. Cells were cultured at 37°C and 5% CO2 in a
humidified atmosphere to P2 prior to hydrogel incorporation.
Growth factor loaded microparticles
Poly (DL-lactide-co-glycolide) (PDLLGA, Lakeshore Biomaterials Inc., USA) microparticles
were prepared using a water-in-oil-in-water (w/o/w) emulsion method as described previously
[59, 60]. Growth factors were dissolved in 100 μL of 10% (w/v) aqueous human serum albumin
(HSA) (120 μg human recombinant VEGF (PeproTech, UK), 40 μg human recombinant TGF-
β3 (PeproTech, UK), 1 mg of human recombinant BMP-2 (in-house Hybridoma construct), or
0.8 mg PTHrP (PeproTech, UK)) and added to a solution of PDLLGA and PDLLGA-PEG (poly
ethylene glycol)-PDLLGA Triblock in dichloromethane to form a primary water-in-oil emul-
sion through homogenisation at 9,000 rpm for 2 min using a Silverson L5M homogeniser (Sil-
verson Machines, UK). A double emulsion was formed through homogenisation in 200 mL
0.3% (w/v) poly vinyl acetate (PVA) solution for 2 min at 9,000 rpm (HSA/BMP-2) or 2,000
rpm (HSA/VEGF, HSA/TGF-β3 and HSA/PTHrP). VitD3 loaded microparticles were fabri-
cated using a single oil-in-water emulsion method by adding 25 μg of VitD3 to the polymer
solution (PDLLGA with 10% PDLLGA-PEG-PDLLGA Triblock in dichloromethane) before
homogenisation at 9,000 rpm for 2 min.
Resultant emulsions were magnetically stirred at 300 rpm for a minimum 4 h before filtra-
tion and lyophilisation of resultant microparticles. Two formulations were implemented for
temporal release of loaded growth factors; fast (large microparticles (50–100 μm) formed with
PDLLGA (85:15, 50 kDa) and 30% (w/w) Triblock copolymer) release profile for HSA/VEGF
and HSA/TGF-β3, and slow (small microparticles (20–30 μm) formed with PDLLGA (50:50,
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55 kDa) with 10% (w/w) Triblock copolymer) release profile for HSA/BMP-2, HSA/PTHrP,
and HSA/VitD3. HSA and/or blank PDLLGA microparticles were used as controls for growth
factors and VitD3 loaded particles, respectively [52].
Growth factors and loading concentrations were selected based on their previously investi-
gated capacity to induce angio-, chondro- and osteo-genesis within SSC populations in vitro
(unpublished data).
Alginate and bone ECM preparation
Low viscosity alginate (Acros Organics, Fisher Scientific, UK) was prepared under sterile con-
ditions as a 2% (w/v) solution in calcium free Dulbecco’s Modified Eagle’s Medium (DMEM,
Invitrogen, UK) and pasteurised for 1 h at 65°C (conventional UV irradiation or autoclaving
damaged cross-linking; 2% solution was too thick for filter sterilisation). Decellularised and
demineralised bone ECM digest (10 mg/mL) was prepared as previously described by Sawkins
M. J. 2013 [52]. Briefly, liquid nitrogen was used to freeze and fragment bovine cancellous
bone, prior to demineralisation for 24 h at room temperature in 0.5 M HCl (25 mL/g bone).
Chloroform/methanol solution (Fisher Scientific, UK) was used to remove lipids before wash-
ing with dH2O, snap freezing and lyophilisation.
Decellularisation was performed through agitation in 0.05% trypsin/0.02% EDTA at 37°C
and 5% CO2 for 24 h before repeat snap freezing and lyophilisation. Prepared bone powder
was subsequently combined with 1 mg/mL pepsin in 0.01 M HCl for a final concentration of
10 mg/mL, and stirred at room temperature for 96 h until the entire matrix was dissolved.
Bone digests were finally aliquoted and stored at -20°C.
Two control hydrogels were prepared to investigate whether the bone ECM component
retained bioactive growth factors; i) bone ECM was replaced with collagen (ALG/Col, Type I
rat tail collagen), ii) bone ECM was irradiated under U.V. overnight (irradiated ALG/ECM).
Collagen was used to replace bone ECM to assess whether effects were attributable to the bone
ECM component. U.V. irradiation was performed to inactivate endogenous growth factors
within bone ECM.
Hydrogel preparation and in vivo implantation
Hydrogels were prepared as a 3:2 mixture (volume) of bone ECM and low viscosity alginate,
respectively. Both growth factor loaded microparticles and human Stro-1+ enriched cells (1 x
106 cells/mL) were incorporated within the hydrogels during formation. 5 mg of appropriate
microparticles were suspended in 5 μL calcium free DMEM and added to each hydrogel so that
final concentrations of bioactive growth factors were 50 ng/mL (VEGF), 15 ng/mL (TGF-β3),
100 ng/mL (BMP2), 100 ng/mL (PTHrP), and 25 nM (VitD3) (based on previous work
describing minimum concentration required to elicit an effect on cell cultures). 1.5 mL hydro-
gel was prepared with 0.4 mL alginate (vortexed with microparticles), 0.6 mL bone ECM digest
and 0.5 mL calcium free DMEM (with or without Stro-1+ cells) and mixed thoroughly between
two syringes attached by a luer lock (NHS Supplies, UK). Afterwards, the mixture was pipetted
into 135 mM calcium chloride for 10 min to allow cross-linking, forming long thin cylindrical
structures. Set hydrogel structures were then incubated in culture media (α-MEM, penicillin
(100 U/mL), streptomycin (0.1 mg/mL) and L-ascorbic acid 2-phosphate (100 μM)) supple-
mented with 2.7 mM calcium chloride overnight at 37°C in 5% CO2 and a humidified atmo-
sphere, to avoid introducing the initial burst release of growth factors from the microparticle
surface in vivo (based on a washing step for the microparticles previously published by Smith
E. L. et al [48, 49]). 5 mm length segments were measured and cut from each hydrogel in prepa-
ration for subcutaneous implantation in vivo within MF1 nu/nu immuno-deficient mice
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bilaterally along the back (3 implants separately spaced per group per side; n = 3). One side
received hydrogel implants with Stro-1+ cell incorporation, whilst the other side received
hydrogel implants without Stro-1+ cell incorporation. Each mouse received one growth factor
loaded hydrogel group. Implants were harvested after 28 days and fixed in 4% paraformalde-
hyde (PFA). Both BMP-2 and VitD3 groups were repeated following promising bone forma-
tion over other growth factors (n = 6, in total).
Micro-computed tomography
Quantitative 3D analysis of hydrogels was performed using a SkyScan 1176 scanning system
(Bruker micro-CT, Kontich). Samples were scanned at 18 μm resolution and reconstructed
using NRecon software interface (v.1.6.4.6, Bruker micro-CT, Kontich). Reconstructed hydro-
gels were analysed using CT Analyser (v.1.13.2.1+, Bruker micro-CT, Kontich) to assess tissue
volume (TV), percentage bone volume (PBV), bone surface to bone volume ratio (BS/BV), tra-
becular number (Tb.N), trabecular thickness (Tb.T), and trabecular separation (Tb.S). Bone
and soft tissue greyscale values were assessed according to standard phantom scans, and intact
mouse bone (forearm) scans. Bone tissue was assessed using greyscale values 80–255 (S1A Fig),
as wider values (60–255) began to highlight soft tissue (S1B Fig). Soft tissue analysis was per-
formed using greyscale values 20–255.
Histology
Following micro-CT analysis, samples were imaged for macroscopic differences using a Power-
Shot G10 camera (Canon) mounted on a stereomicroscope (Leica, UK). Samples were then
dehydrated through a series of ethanol washes (50%, 90% and 100% in dH2O) and incubation
within Histo-Clear (National Diagnostics, UK). Following incubation in paraffin wax for 1 h at
60°C, samples were embedded in wax blocks using an automated Shandon Citadel 2000. Con-
secutive 7 μm thick sections were rehydrated through Histo-Clear, graded ethanol and dH2O
before staining with Alcian blue/Sirius red (A/S), Von Kossa (VK), and Goldner’s Trichrome
(GT). A/S involved staining with Weigert’s haematoxylin, 0.5% Alcian blue (stains proteogly-
can-rich cartilage matrix), and 1% Sirius red (stains collagenous matrix). VK involved staining
with silver nitrate (under U.V.), sodium thiosulfate, Alcian blue, and van Gieson. GT involved
staining with Weigert’s haematoxylin, ponceau-fuchsin-azophloxin, phosphomolybdic acid,
and light green. Sections were then dehydrated and mounted with DPX before imaging on an
Olympus BX-51/22 dotSlide digital virtual microscope using OlyVIA 2.1 software (Olympus
Soft Imaging Solutions, GmBH, UK). Duplicate sections per sample were processed for each
stain (n = 3 to 6 samples).Additional sections were treated with hydrogen peroxide (3% in
dH2O) to quench endogenous peroxidase activity. Sections were incubated with blocking
buffer (1% BSA in PBS) for 15 min then primary antibody solution (anti-vonWillebrand factor
(vWF) or anti-vimentin) overnight at 4°C. Biotinylated secondary antibody (1:200 in blocking
buffer) was applied for 1 h prior to incubation with avidin-conjugated peroxidase. Sections
were treated with 3-amino-9-ethylcarbazole for 10 min or until a red-brown reaction product
could be visualised. Stained sections were subsequently washed and counterstained with
haematoxylin.
Histomorphometry
Quantification of growth parameters including tissue invasion, matrix deposition, mineralisa-
tion, and vascularisation was performed through colour threshold analysis of scanned images
using an optimised macro in Fiji (Image J) [63]. Initially a ‘region of interest’ (ROI) was drawn
around the total area of each hydrogel sample before further ROIs were created highlighting
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missing or torn areas of hydrogel, and both selections were saved as a ROI file. Automated
analysis using the macro was then performed on all images using corresponding ROI files (S2A
Fig). The macro functioned through ‘colour threshold’ selection (hue, saturation and bright-
ness values; 0–255) and creation of a black (selected colour) and white (non-selected colour)
mask. A point grid was then overlaid on the masks where each point constituted 5 by 5 pixels;
approximate resolution of a single cell. Saved ROIs were then applied to define areas for quan-
tification. Both positive points ( 50% black pixels) and total number of points within the sam-
ple area were counted and used to calculate the selected colour as a percentage of the total
sample. Points corresponding to torn ROIs were added where appropriate.
A/S–blue (hue 120–150, saturation 50–255, brightness 0–255) represented proteoglycans
and residual hydrogel, red (hue 210–255, saturation 20–255, brightness 0–255) represented tis-
sue invasion, and purple (hue 140–200, saturation 50–255, brightness 140–255) represented
collagen deposition (S2B Fig).
VK—black (hue 0–255, saturation 0–255, brightness 0–100) represented mineralisation,
and pink (hue 170–255, saturation 100–255, brightness 50–255) represented cell invasion (S2C
Fig).
GT—green represented osteoid, purple represented cell invasion, and red represented eryth-
rocytes (S2D Fig). Quantification of erythrocytes (identified by colour and morphology)
assessed vascularisation of the hydrogel constructs. A square grid of known size (200 μm) was
overlaid on each image and the number of squares containing bright red erythrocytes were
counted and calculated as a percentage of the total number of squares covering the area of the
hydrogel. Macro quantification could not be used to assess red staining due to low occurrence
and surface area.
All hydrogel implants exhibited areas of dense stain which were torn and shredded. These
areas were quantified (S3Ai and S3Bi Fig) and added to the total area of the immediate sur-
rounding colour (blue in A/S red stains, and black in VK stains). Similar statistical results were
observed compared to datasets without torn area incorporation (S3Aii, S3Bii, S9A and S10A
Figs).
Statistical analysis
All data sets are presented as mean +/- standard deviation. Statistical analysis was performed
using GraphPad InStat3 v3.06 software. Differences between experimental groups were deter-
mined for statistical significance by use of a one-way ANOVA with Tukeys multiple compari-
son test. Intra-group differences between those with and without Stro-1+ cells were assessed by
a Welch corrected unpaired t-test. Correlation between datasets was assessed using a linear
regression model (Pearson). ‡ denotes positive correlation. Emboldened columns denote intra-
group significance. Significance is depicted as  P 0.05,  P 0.01,  P 0.001.
Results
Hydrogel mineralisation and bone formation assessed by micro CT
analysis
Following harvest, after 28 days implantation, hydrogel samples were imaged by stereomicro-
scopy (S4 Fig) prior to micro CT assessment of bone formation (Fig 1). There were no major
differences in the appearance of hydrogels between growth factor groups or between samples
with and without Stro-1+ cell incorporation. All samples exhibited similar blood vessel and tis-
sue invasion upon examination and micro CT analysis showed no significant differences in tis-
sue volume (TV) between any two individual hydrogel groups (Fig 1A). Large opaque white
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areas could be seen in most samples which were rigid upon manipulation and therefore poten-
tial areas of mineralisation. Minimal or no opaque areas were observed within HSA/TGF-β3
Fig 1. Micro CT analysis of hydrogels following 28 days in vivo implantation. Tissue volume (A), percentage bone volume (B), bone surface to volume
ratio (C), trabecular number (D), trabecular thickness (E) and trabecular separation (F) were all assessed between growth factor groups. Emboldened
columns depict statistically significant intragroup differences between those with and without Stro-1+ cell incorporation. Asterisks depict statistical difference
between the group above which the asterisk is positioned and all the other groups; if positioned centrally above both groups with and without Stro-1+ cell
incorporation, statistical difference was observed for both compared across all groups. Error bars are S.D. * P 0.05, ** P 0.01, *** P 0.001.
doi:10.1371/journal.pone.0145080.g001
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hydrogels, supported by negligible bone tissue formation evidenced through micro CT analysis
(Fig 1B).
No groups were significantly different compared to control ALG/ECM for any parameter
assessed by micro CT. However, significant differences were observed in comparison to control
irradiated ALG/ECM, including significantly (P 0.05) greater bone formation observed
within both HSA/BMP-2 and HSA/VitD3 groups (Fig 1B). HSA/VitD3 exhibited significantly
higher trabecular thickness (Tb.T) (P0.05) compared to all other groups except HSA/PTHrP
(Fig 1E). ALG/ECM, BMP-2 and VitD3 demonstrated significantly (P 0.05) increased per-
centage bone volume (PBV) compared to control irradiated ALG/ECM (dependent on Stro-1
+ cell incorporation) and chondrogenic factor TGF-β3. Indeed, ALG/ECM and HSA/BMP-2
without incorporation and HSA/VitD3 with incorporation exhibited significantly (P 0.05)
enhanced bone formation. Interestingly, HSA/BMP-2 and HSA/VitD3 often exhibited signifi-
cant (P 0.05) intra-group differences between those with and without Stro-1+ cells (S7 Fig).
HSA/TGF-β3 and HSA/PTHrP were also shown to exhibit significant intra-group differences,
dependent on bone parameter. HSA/TGF-β3 exhibited significantly (P 0.01) greater bone
surface to bone volume ratio (BS/BV) and trabecular number (Tb.N), but lower (P 0.05) Tb.
T compared to all other groups except HSA/PTHrP, dependent on Stro-1+ cell incorporation.
Host cell/tissue invasion and mineralisation assessed by histological
analysis
Following micro CT analysis, hydrogels were assessed histologically to determine the degree of
bone formation and host tissue invasion. A number of histological stains were assessed to high-
light different components within the hydrogels. Following staining with Von Kossa, areas of
mineralised tissue were observed in all hydrogel samples (Fig 2). Areas of dense black were uni-
formly torn and shredded across all samples, typical of mineralised bone upon sectioning.
Clear differences could be seen between growth factor groups including reduced mineralisation
within irradiated ALG/ECM, HSA/VEGF, HSA/TGF-β3 and HSA/PTHrP (Fig 2A, 2E, 2F and
2H, respective). Histological stains were subsequently quantified for comparison using a spe-
cialised Image J macro (S2A Fig). Control non-implanted hydrogels were also histologically
assessed (S8 Fig). Interestingly, hydrogels stained strongly with Alcian blue (S8A Fig). No stain
was observed within Von Kossa and Goldner’s Trichrome stained control hydrogels (S8B and
S8C Fig). Incorporated Stro-1+ cells were observed homogeneously spread throughout each
hydrogel (depicted by white arrows).
Alcian blue/Sirius red. Within an Alcian blue and Sirius red section, blue areas typically
denote proteoglycan deposition, however control non-implanted hydrogels were also heavily
stained blue (S8A Fig). Consequently, blue quantification assessed both proteoglycan deposi-
tion and residual hydrogel following implantation (Fig 3A). Significantly (P 0.01) reduced
proteoglycan deposition and residual hydrogel was observed within most growth factor groups
excluding ALG/ECM, HSA/BMP-2 and HSA/VitD3 compared to irradiated ALG/ECM (S9A
Fig). Control HSA demonstrated significantly (P 0.05) reduced proteoglycan deposition and
residual hydrogel compared to all groups except HSA/VEGF, dependent on Stro-1+ cell incor-
poration. Indeed, most differences observed were dependent on Stro-1+ cell incorporation. Sig-
nificant intra-group differences were observed within HSA/TGF-β3, HSA/BMP-2 and HSA/
PTHrP groups.
Purple stain indicated areas of collagen deposition within the original hydrogel; usually
collagen is red, but due to the intense blue stain of the original hydrogel, these areas appeared
purple (Fig 3B). Only HSA without, and HSA/VEGF and HSA/PTHrP with Stro-1+ cells,
exhibited significantly (P 0.05) greater collagen deposition compared to all other groups
Alginate/Bone ECMHydrogel for Bone Regeneration
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(S9B Fig). HSA/VitD3 exhibited significantly (P 0.01) lower collagen deposition compared
to HSA dependent on Stro-1+ cell incorporation. Significant intra-group differences were
observed within HSA, HSA/BMP-2 and HSA/PTHrP groups.
Red stained tissue, typically considered collagenous matrix, corresponded to host tissue
invasion and was observed histologically as a fibrous network of threads infiltrating the hydro-
gel boundaries and occasionally spanning the width of the hydrogel (S2B and S2C Fig). Where
blue colouration accounted for up to 80% of the hydrogel area, red accounted for 10%, simi-
lar to that for collagen deposition (Fig 3C). Overall, the three colours accounted for close to
100% of the hydrogel area. Minimal significant differences across groups were observed in
comparison to control ALG/ECM. However, HSA/VEGF with Stro-1+ cell incorporation
exhibited significantly (P 0.05) greater tissue invasion compared to irradiated ALG/ECM,
ALG/ECM, HSA/TGF-β3 and HSA/BMP-2 (S8C Fig). Other significant inter-group differ-
ences included HSA/VitD3 compared to irradiated ALG/ECM, ALG/ECM and HSA/BMP-2,
where HSA/VitD3 exhibited significantly (P 0.05) greater tissue invasion, dependent on
Fig 2. Hydrogel mineralisation between growth factor groups following 28 days in vivo implantation.Groups included irradiated ALG/ECM (A), ALG/
Col (B), ALG/ECM (C), ALG/ECMHSA (D), ALG/ECMHSA/VEGF (E), ALG/ECMHSA/TGF-β3 (F), ALG/ECMHSA/BMP-2 (G), ALG/ECM HSA/PTHrP (H)
and ALG/ECMHSA/VitD3 (I). Images were taken at high (scale bar is 500 μm) and low magnification (box inserts–scale bar is 50 μm).
doi:10.1371/journal.pone.0145080.g002
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Fig 3. Histological analysis of hydrogels stained with Alcian blue/Sirius red. Hydrogels were subcutaneously implanted within immunodeficient for 28
days. Colour quantification was through the use of an optimised Image J macro (S2 Fig). Blue indicated proteoglycan deposition and residual hydrogel (A),
purple indicated collagen deposition within the hydrogel (B) and red indicated tissue invasion (C). Emboldened columns depict statistically significant
intragroup differences between those with and without Stro-1+ cell incorporation. Asterisks depict statistical difference between the group above which the
asterisk is positioned and all the other groups; if positioned centrally above both groups with and without Stro-1+ cell incorporation, statistical difference was
observed for both compared across all groups. Error bars are S.D. * P 0.05, ** P 0.01, *** P 0.001.
doi:10.1371/journal.pone.0145080.g003
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Stro-1+ cell incorporation. Significant intra-group differences were only observed within the
HSA/VitD3 group.
Von Kossa. Mineralised tissue, indicative of new bone tissue formation, was confirmed by
intense black stain following Von Kossa analysis within the hydrogels. ALG/ECM was not sig-
nificantly different from either HSA/BMP-2 or HSA/VitD3, and all 3 groups exhibited signifi-
cantly (P 0.001) increased mineralisation compared to all other groups including irradiated
ALG/ECM (Fig 4A). Interestingly, results were very different between those groups with Stro-1
+ cell incorporation and those without (S10A Fig). In the absence of Stro-1+ cells, only ALG/
ECM and HSA/VitD3 exhibited enhanced mineralisation compared to most, but not all, other
groups. Conversely, without Stro-1+ cell incorporation HSA/BMP-2 exhibited enhanced
mineralisation in comparison to irradiated ALG/ECM. When Stro-1+ cells were not incorpo-
rated, HSA/TGF-β3 exhibited significantly (P 0.001) reduced mineralisation in comparison
to all other groups. No significant intra-group difference were observed within ALG/ECM,
Fig 4. Histological analysis of hydrogels stained with Von Kossa.Hydrogels were subcutaneously implanted within immunodeficient mice for 28 days.
Colour quantification was through the use of an optimised Image J macro (S2 Fig). Black indicates mineralised tissue (A) and pink indicates cell invasion (B).
Emboldened columns depict statistically significant intragroup differences between those with and without Stro-1+ cell incorporation. Asterisks depict
statistical difference between the group above which the asterisk is positioned and all the other groups; if positioned centrally above both groups with and
without Stro-1+ cell incorporation, statistical difference was observed for both compared across all groups. Error bars are S.D. * P 0.05, ** P 0.01,
*** P 0.001.
doi:10.1371/journal.pone.0145080.g004
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HSA/BMP-2 and HSA/VitD3 groups, however significant (P 0.05) intra-group differences
were observed in all other groups except ALG/Col.
Many dense areas which were damaged and shredded lay within the Von Kossa regions
(black areas), typical of mineralised tissue during histological sectioning (S2Ci Fig). Conse-
quently, these areas were included in quantification of black areas and assessed separately
(S3Bi Fig). No growth factor groups exhibited significantly increased mineralisation compared
to control ALG/ECM, with or without consideration of torn and shredded areas. Indeed, care-
ful comparison revealed comparable trends between groups, independent of torn/shredded
area quantification (Fig 4A, S3Bi, S3Bii and S9A Figs).
Pink colouration highlights cell cytoplasm and therefore provides an assessment of host cell
invasion. In this instance the stain also highlights collagen (S2Ciii Fig) and therefore closely
reflects red staining in Alcian blue/Sirius red. The results show similar, but not identical trends
between both datasets (Figs 3C and 4B). HSA/TGF-β3 with Stro-1+ cell incorporation exhib-
ited significantly (P 0.05) increased cell invasion compared to irradiated ALG/ECM, ALG/
ECM and HSA/BMP-2. HSA/VEGF without Stro-1+ cell incorporation exhibited significantly
(P 0.05) increased cell invasion compared to ALG/ECM, HSA/TGF-β3, HSA/BMP-2 and
HSA/VitD3. Other inter-group differences included HSA/BMP-2 compared to HSA/VEGF
both with Stro-1+ cells, and HSA compared to HSA/VitD3 both without Stro-1+ cells (S10C
Fig). HSA/TGF-β3, HSA/BMP-2, HSA/PTHrP and HSA/VitD3 all exhibited significant
(P 0.05) intra-group differences where Stro-1+ cell incorporation had a positive effect on cell
invasion, except in HSA/BMP-2 groups.
Goldner’s Trichrome. Erythrocytes stained bright red following histological processing
for Goldner’s Trichrome (Fig 5A). Erythrocyte presence was used to assess hydrogel vasculari-
sation by host tissue (Fig 5B and S11 Fig). No significant differences were observed between
any two groups except irradiated ALG/ECM and HSA/PTHrP, without Stro-1+ cell incorpo-
ration (S12 Fig). No intra-group differences were observed. Positive immuno-labelling for
vWF within and outside the hydrogels supported the identification of blood vessel formation
(S13A and S13B Fig).
Following colour quantification, data across growth factor groups was collated and correla-
tion analysis between stains was assessed (S14 Fig). Correlation analysis provided assessment
of internal mechanisms during host invasion and cellular colonisation. Residual hydrogel and
Fig 5. Histological analysis of hydrogels stained with Goldner’s Trichrome. Hydrogels were subcutaneously implanted within immunodeficient mice for
28 days. A square grid (200 μm) overlay was used to quantify erythrocytes (A) and assess vascularisation (B). Error bars are S.D. * P 0.05.
doi:10.1371/journal.pone.0145080.g005
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proteoglycan deposition decreased with host invasion. Importantly however, residual hydrogel
did not correlate with mineralised tissue. Tissue invasion positively correlated with cell inva-
sion, collagen deposition and vascularisation. Interestingly, tissue invasion did not correlate
with mineralisation. Correlations were independent of Stro-1+ cell incorporation. However,
only groups with Stro-1+ cell incorporation demonstrated positive correlation between colla-
gen deposition and cell invasion/vascularisation, and negative correlation between collagen
deposition/cell invasion and mineralisation.
Following in vivo culture, in an attempt to identify which tissues were contributed to by the
implanted cells, sectioned samples were immuno-labelled with anti-human vimentin antibod-
ies, a universally expressed marker on all possible differentiated cell types. However, the
authors were unable to identify the implanted human Stro-1+ cells, possibly due to the low
seeding density (S13C Fig). Work run in parallel with this study identified a lack of cell prolif-
eration following implantation within these hydrogels [48, 49]; it is therefore conceivable that
the implanted human cells perished and after in vivo culture there were minimal to no human
cells remaining.
Discussion
The current study has explored a multifactorial approach towards bone development and tissue
engineering utilising ALG/ECM hydrogels in vivo. Growth factor loaded-microparticles and
Stro-1+ SSCs were incorporated to increase mineralisation and further enhance bone forma-
tion. Interestingly, all hydrogel groups formed mineralised tissue following ectopic subcutane-
ous in vivo implantation for 28 days. Indeed no individual growth factor significantly
enhanced mineralisation compared to control ALG/ECM, as a possible consequence of
retained inherent growth factors within the bone ECM component [52, 64, 65]. This hypothesis
is partially supported by reduced bone formation observed within irradiated ALG/ECM sam-
ples. Exposure to UV can cause growth factor degradation, but also alginate degradation and
increased cross-linking. High levels of cross-linking within the ECM component as a result of
UV irradiation has been shown to increase enzymatic resistance, a favourable property for
load-bearing applications, such as bone tissue engineering [66]. γ-irradiation of alginate has
been shown to significantly reduce polymerization undermining hydrogel stability [67]. How-
ever, a recent study has shown that UV irradiation did not affect mechanical properties within
alginate scaffolds [68]. Consequently, reduced bone formation within UV irradiated hydrogels
was due to inherent growth factor degradation. UV irradiation effects on the molecular struc-
ture of collagen within ECM component may also have contributed to these observations.
Although not statistically significant, the numerical reduction in bone formation and vasculari-
sation between ALG/ECM and ALG/Col also supports the hypothesis that ECM has inherent
growth factors. Larger sample numbers and increased replicates may have helped these numer-
ical differences reach statistical significance. The current results suggest bone ECM is an inex-
pensive, osteoinductive biomaterial with potential applications for tissue engineering and
regenerative medicine, as observed in our previous ex vivo organotypic studies [48, 49].
Interestingly, enhanced bone formation was not observed within HSA/BMP-2 groups with
Stro-1+ cell incorporation, compared to irradiated ALG/ECM. Without Stro-1+ cell incorpo-
ration HSA/BMP-2 exhibited significantly greater bone formation, similar to VitD3, compared
to irradiated ALG/ECM; potentially through formation of thicker trabeculae. Indeed, these
significant differences in comparison to irradiated ALG/ECM highlighted the inherent osteoin-
ductive efficacy of bone ECM, as possible growth factor degradation via irradiation signifi-
cantly decreased bone formation. Importantly, the osteoinductive capacity of control ALG/
ECM was such that neither osteogenic factor, BMP-2 nor VitD3, could further enhance bone
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formation. The bone ECM component was observed to be highly osteoinductive possibly due
to inherent growth factors. Addition of osteogenic factors at the concentrations employed in
these studies did not further enhance bone formation.
Increased bone formation was in part, dependent on incorporation of Stro-1+ cells. Thera-
peutic SSC incorporation can reconstitute microenvironmental cues within hydrogels through
their secretome (growth factors, micro-vesicles, and exosomes released into the extracellular
milieu) [69]. Combination of SSCs within several collagen-based hydrogels has previously
yielded improved osteochondral tissue formation [70–75]. Although BMP-2 and VitD3 dem-
onstrated similarly increased bone formation, their response to cell incorporation was quite
different. Interaction of BMP-2 and Stro-1+ cells led to decreased bone formation, whilst inter-
action with VitD3 increased bone formation. PBV takes into consideration TV and therefore
formation of potential pre-mineralised tissues such as osteoid. Enhanced bone formation
within HSA/BMP-2, unlike HSA/VitD3, was dependent on the absence of Stro-1+ cell incorpo-
ration, and significant intra-group difference suggests the presence of Stro-1+ cells did not aug-
ment BMP-2 induced bone formation. It is possible that Stro-1+ cells were highly responsive to
BMP-2 signalling and differentiated without proliferation; less cells, less bone formation. Alter-
natively, and possibly more accurately, the presence of Stro-1+ cells may have limited or inhib-
ited BMP-2 induced bone formation.
Chondrogenic HSA/TGF-β3 groups did not enhance cartilage formation, possibly due to
inadequate concentration, spatiotemporal delivery, or reduced cells evidenced by the lack of
increased total TV and proteoglycan deposition. Our studies indicate TGF-β3 inhibited bone
formation; in marked contrast to the osteoinductive effect of ALG/ECM. Further micro CT
analysis revealed that TGF-β3 delivery affected bone structure increasing the number of bone
trabeculae compared to HSA/BMP-2 and HSA/VitD3, which in turn significantly increased
BS/BV values. It is generally accepted that higher numbers of thick trabeculae provide the
greatest structural strength in 3D bone tissue and therefore reduced Tb.N and high BS/BV fol-
lowing TGF-β3 signalling resulted in lower bone formation of potentially inferior mechanical
strength. These structural differences were only significant when hydrogels were seeded with
Stro-1+ cells, suggesting the cells amplified the effect of TGF-β3, again through potential inhib-
itory and counter-osteogenic signalling. VEGF and PTHrP did not significantly affect bone for-
mation or bone structure according to micro CT data, possibly due to resolution limitations
with a scan at 18 μm resolution; if VEGF and PTHrP affected bone formation but on a rela-
tively smaller scale than other growth factors, these changes may not have been resolved at
18 μm resolution. Alternatively, extensive host-driven vascularisation in all groups may have
superseded any effect from implanted VEGF; supported by the lack of difference in vascularisa-
tion between groups. PTHrP may not have been present at sufficient concentrations to elicit an
observable effect on bone formation.
All hydrogel groups investigated exhibited areas of mineralised tissue following Von Kossa
staining indicating capacity for bone formation. Subsequent to these studies Lee C. S. et al [76]
reported on passive calcification of alginate microbeads following in vivo implantation subcu-
taneously within mice. However, quantification of torn/shredded calcified alginate areas within
our hydrogel implants did not significantly affect observed differences between groups, nor did
residual hydrogel correlate with mineralisation/calcification. To avoid issues with passive calci-
fication in future, alginate cross-linking with barium chloride rather than calcium chloride
would be optimal. The histological trends reflected those observed from micro CT analysis,
where HSA/BMP-2, HSA/VitD3 and control ALG/ECM exhibited the greatest mineralised tis-
sue formation, but were not significantly different from each other. Osteogenic growth factors
did not further enhance bone formation within our hydrogels due to the inherent osteoinduc-
tive capacity of the bone ECM component. In support, irradiated ALG/ECM exhibited
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significantly reduced mineralisation through possible degradation of the inherent growth fac-
tors, although other effects of UV irradiation on the molecular structure of collagen within the
ECM component may have contributed to these reductions. Incorporation of inducible Stro-1
+ cells was important for bone formation, dependent on the growth factor present. Delivery
alongside angiogenic or chondrogenic growth factors actively reduced bone formation follow-
ing histological assessment compared with micro CT analysis. Importantly, these same groups
without cell incorporation did not demonstrate the same reduction in bone formation.
Extensive host tissue invasion within all hydrogel samples hindered analysis of tissue forma-
tion originating directly from incorporated Stro-1+ cells. Indeed, cell invasion positively corre-
lated with host tissue invasion, appearing as a cell dense collagenous network throughout the
hydrogel structure. Within angiogenic and chondrogenic groups, soft tissue formation either
replaced original hydrogel during potential resorption, or contributed to the original hydrogel
volume restructuring internal composition. However, since residual hydrogel negatively corre-
lated with host invasion, the former suggestion appears most likely. In general, ALG/ECM and
osteogenic groups exhibited increased mineralisation without change to hydrogel volume,
again supporting replacement rather than addition. Bone ECM provided both hydrogel inva-
sion points and internal structural conduits for host cell migration. Host blood vessels migrated
into all hydrogel samples together with aggressive tissue and cell invasion, minimising inter-
group differences. However, quantification of vascularisation was based on erythrocyte pres-
ence, which does not accurately reflect the number or size of blood vessels, only presence.
Although the hydrogel system described here has shown value for in vivo bone formation,
interpretation to the clinical setting requires further study. The hydrogel system demonstrated
capacity for bone formation in vivo even in the ectopic location utilised here. However, this
also highlights a major limitation of the study, as subcutaneous implantation lacks the mechan-
ical stresses that the hydrogel system would need to experience/perform under in the clinical
arena. A second limitation is the fact the hydrogel system was implanted within immuno-com-
promised mice. Although alginate has been used in the clinical setting for a number of decades
(e.g. wound dressings) further investigation would be required to ascertain whether the hydro-
gel system would elicit an immune response.
Conclusion
The current studies demonstrate the application of an ALG/ECM hydrogel system for in vivo
bone formation. The bone ECM component exhibited inherent osteoinductive capacity leading
to enhanced mineralisation which was not further enhanced with additional growth factor con-
centrations applied in this study. Structural stabilisation of liquid ECM such that the hydrogel
could be shaped and manipulated was afforded by combination with alginate. Bone formation
within the hydrogel system could be altered with chondrogenic growth factors such that the
system formed greater soft tissue. Taken together, ALG/ECM offers a bioactive alternative scaf-
fold for utilisation within regenerative medicine, which may be further tailored, ultimately, to
form the tissue of choice through incorporation of select growth factor-loaded microparticles.
This study has shown the potential of a multifaceted approach to bone development and tissue
engineering.
Supporting Information
S1 Fig. Micro CT analysis of intact adult mouse limb (forearm). Greyscale threshold at 80–
255 (A) shows only mineralised tissue, whilst 60–255 (B) shows both mineralised and soft tis-
sue.
(TIF)
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S2 Fig. Histological analysis of hydrogels implanted within immunodeficient mice for 28
days. A specialised macro on Image J was designed to quantify colours on histology images
(A). First, the hydrogel was selected by drawing a ‘region of interest’ (Ai). ‘Colour threshold’
was then used to create a black and white mask (Aii). A point grid overlaid on the mask was
used to quantify the colour (Aiii). Images were taken at low (i), medium (ii) and high magnifi-
cation (iii). Consecutive sections were stained with Alcian blue/Sirius red (B), Von Kossa (C)
and Goldner’s Trichrome (D). White arrows depict colour that have been quantified on each
histological stain.
(TIF)
S3 Fig. Histological analysis of torn/shredded areas within hydrogel samples following
Alcian blue/Sirius red (A) and Von Kossa stain (B).Hydrogels were subcutaneously
implanted within immunodeficient for 28 days. Colour quantification was through the use of
an optimised Image J macro (S2 Fig). Blue indicated proteoglycan deposition and residual
hydrogel (Ai) and black indicated mineralisation (Bi). Comparison between all groups with
Stro-1+ cells (upper right corner–light grey) or without Stro-1+ cells (lower left corner–
medium grey) were assessed by a One Way ANOVA with Tukeys post-hoc test (ii). Dark grey
boxes depict t-test comparisons within groups between those with and without Stro-1+ cells.
Emboldened columns depict statistically significant intragroup differences between those with
and without Stro-1+ cell incorporation. Asterisks depict statistical difference between the
group above which the asterisk is positioned and all the other groups; if positioned centrally
above both groups with and without Stro-1+ cell incorporation, statistical difference was
observed for both compared across all groups. Red box indicates non-comparison as irradiated
ALG/ECM did not have Stro-1+ cells incorporated. NS indicates ‘no significance’.  P 0.05,
 P 0.01,  P 0.001.
(TIF)
S4 Fig. Hydrogels following harvest from immunodeficient mice after 28 days implanta-
tion. Scale bar is 5 mm.
(TIF)
S5 Fig. Statistical analysis of micro CT data between growth factor groups with Stro-1+ cell
incorporation. All data was analysed using One Way ANOVA with Tukeys post-hoc test.
Tables separate into upper right and lower left corners detailing individual comparisons
between all groups regarding the parameter stated adjacent. ‘NS’ indicates no significance.
 P 0.05,  P 0.01,  P 0.001.
(TIF)
S6 Fig. Statistical analysis of micro CT data between growth factor groups without Stro-1
+ cell incorporation. All data was analysed using One Way ANOVA with Tukeys post-hoc
test. Tables separate into upper right and lower left corners detailing individual comparisons
between all groups regarding the parameter stated adjacent. ‘NS’ indicates no significance.
 P 0.05,  P 0.01,  P 0.001.
(TIF)
S7 Fig. Statistical analysis of micro CT data between those groups with and without Stro-
1+ cell incorporation. NS indicates ‘no significance’.  P 0.05,  P 0.01.
(TIF)
S8 Fig. Histological analysis of control non-implanted hydrogels with Stro-1+ cell incorpo-
ration stained with Alcian blue/Sirius red (A), Von Kossa (B), and Goldner’s Trichrome
(C). Images were taken at low (i, scale bar is 500 μm) and high (ii, scale bar is 100 μm)
Alginate/Bone ECMHydrogel for Bone Regeneration
PLOS ONE | DOI:10.1371/journal.pone.0145080 December 16, 2015 17 / 23
magnification.
(TIF)
S9 Fig. Statistical analysis of histology data between growth factor groups from Alcian
blue/Sirius red stained sections. Residual hydrogel and proteoglycan deposition (A), collagen
deposition (B) and tissue invasion (C) were each statistically analysed. Comparison between all
groups with Stro-1+ cells (upper right corner–light grey) or without Stro-1+ cells (lower left
corner–medium grey) were assessed by a One Way ANOVA with Tukeys post-hoc test. Dark
grey boxes depict t-test comparisons within groups between those with and without Stro-1
+ cells. Red box indicates non-comparison as irradiated ALG/ECM did not have Stro-1+ cells
incorporated. NS indicates ‘no significance’.  P 0.05,  P 0.01,  P 0.001.
(TIF)
S10 Fig. Statistical analysis of histology data between growth factor groups from Von
Kossa stained sections.Mineralisation (A) and cell invasion (B) were both statistically ana-
lysed. Comparison between all groups with Stro-1+ cells (upper right corner–light grey) or
without Stro-1+ cells (lower left corner–medium grey) were assessed by a One Way ANOVA
with Tukeys post-hoc test. Dark grey boxes depict t-test comparisons within groups between
those with and without Stro-1+ cells. Red box indicates non-comparison as irradiated
ALG/ECM did not have Stro-1+ cells incorporated. NS indicates ‘no significance’.  P 0.05,
 P 0.01,  P 0.001.
(TIF)
S11 Fig. Extensive vascularisation throughout the implanted hydrogel structure depicted
by the presence of erythrocytes.Host blood vessel invasion is depicted by white arrows within
magnified areas. Image was taken from a GT stained ALG/ECM hydrogel following 28 days in
vivo implantation.
(TIF)
S12 Fig. Statistical analysis of hydrogels stained with Goldner’s Trichrome. Comparisons
between all groups with Stro-1+ cells (upper right corner–light grey) or without Stro-1+ cells
(lower left corner–medium grey) were assessed by a OneWay ANOVA with Tukeys post-hoc
test. Dark grey boxes depict comparisons within groups between those with and without Stro-1
+ cells. Red box indicates non-comparison as irradiated ALG/ECM did not have Stro-1+ cells
incorporated. NS indicates ‘no significance’.  P 0.05.
(TIF)
S13 Fig. Blood vessel formation and identification of human tissue. Positive red-brown
staining for vWF (depicted by white arrows) identified blood vessel formation in the mouse tis-
sue surrounding the hydrogel (A) and in the tissues invading the hydrogel (B). Samples stained
for human-specific vimentin did not identify implanted Stro-1 cells (C). Sections were counter-
stained with haematoxylin. Scale bars measure 100 μm.
(JPG)
S14 Fig. Statistical analysis of correlations between histologically assessed parameters. Fol-
lowing colour quantification of A/S, VK and GT stained samples, data for residual hydrogel
and proteoglycan deposition (blue), tissue invasion (red), collagen deposition (purple), minera-
lisation (black), cell invasion (pink) and vascularisation (RBC presence) was combined across
all growth factor groups and correlations between colours were assessed. Top right graphs
depict correlations between all groups with Stro-1+ cell incorporation. Bottom left graphs
depict correlations between all groups without Stro-1+ cell incorporation. Trend lines highlight
those graphs depicting significant correlation. NS indicates ‘no significance’. ‡ denotes positive
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correlation.  P 0.05,  P 0.01,  P 0.001.
(JPG)
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